QQQS Invesco NASDAQ Future Gen 200 ETF
Quote as of Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 45.08 | Day Range | 44.98 – 45.06 |
| 52-Week Range | 30.11 – 45.44 | Volume | 3.55K |
| Avg Volume | 7.85K | AUM | $23.1M (Aug 27, 2026) |
| Expense Ratio | 0.20% | Yield (TTM) | 2.49% |
| NAV | 45.23 | Premium/Discount | -0.38% indicative |
| Inception | Oct 13, 2022 | Holdings | 202 |
| Issuer | Invesco | Exchange | NASDAQ |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 46138G482 | ISIN | US46138G4828 |
| Management | Not stated in source data | ||
About this ETF
The Invesco NASDAQ Future Gen 200 ETF (the Fund) aims to provide exposure to the Nasdaq Innovators Completion Cap Index (the Index). To achieve this, the Fund allocates at least 90% of its total assets to the securities that comprise the Index. The Index itself is composed of 200 small-capitalization companies, which Nasdaq selects based on the relative value of their patent portfolios compared to their overall market capitalization. These eligible companies are drawn from the Nasdaq Composite Index, specifically excluding those already included in the Nasdaq-100 Index and Nasdaq Next Generation 100 Index. Every company within the Index is equally weighted. Both the Fund and the Index are updated regularly, with rebalancing occurring quarterly and reconstitution happening semi-annually.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +7.28% | +2.87% | +22.74% | +32.13% | +48.02% | +20.68% | — | — | +16.02% |
| Total return | +7.29% | +2.95% | +23.05% | +32.45% | +53.01% | +22.71% | — | — | +17.67% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 26, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.20% | Annual cost of a $10,000 investment | $20.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 22, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 207 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Cybin Inc | HELP | 1.35% | 24.61K | $306.8K |
| 2 | Xencor Inc | XNCR | 1.12% | 9.42K | $254.4K |
| 3 | 10X Genomics Inc | TXG | 1.11% | 3.96K | $252.6K |
| 4 | Iovance Biotherapeutics Inc | IOVA | 1.08% | 27.31K | $245.5K |
| 5 | Agenus Inc | AGEN | 1.05% | 31.99K | $239.6K |
| 6 | Quantum Corp | QMCO | 1.04% | 11.53K | $236.2K |
| 7 | Neuronetics Inc | STIM | 0.99% | 72.70K | $224.6K |
| 8 | Varex Imaging Corp | VREX | 0.89% | 10.94K | $202.4K |
| 9 | AtriCure Inc | ATRC | 0.85% | 4.05K | $192.1K |
| 10 | Precigen Inc | PGEN | 0.84% | 25.80K | $191.9K |
| 11 | Newell Brands Inc | NWL | 0.84% | 32.93K | $190.7K |
| 12 | Omeros Corp | OMER | 0.83% | 10.14K | $188.9K |
| 13 | Azenta Inc | BRKS | 0.79% | 4.89K | $178.6K |
| 14 | Exagen Inc | XGN | 0.77% | 22.45K | $174.7K |
| 15 | TriSalus Life Sciences Inc | TLSI | 0.76% | 32.83K | $171.7K |
| 16 | OrthoPediatrics Corp | KIDS | 0.75% | 6.52K | $171.0K |
| 17 | Rigel Pharmaceuticals Inc | RIGL | 0.73% | 3.67K | $166.2K |
| 18 | Personalis Inc | PSNL | 0.73% | 9.82K | $165.8K |
| 19 | Anika Therapeutics Inc | ANIK | 0.72% | 7.71K | $164.4K |
| 20 | Q32 Bio Inc | QTTB | 0.71% | 10.13K | $160.7K |
| 21 | Merit Medical Systems Inc | MMSI | 0.70% | 1.77K | $160.1K |
| 22 | Rapid7 Inc | RPD | 0.70% | 13.36K | $158.2K |
| 23 | MillerKnoll Inc | MLKN | 0.69% | 6.92K | $157.5K |
| 24 | Aclaris Therapeutics Inc | ACRS | 0.69% | 24.61K | $155.8K |
| 25 | SI-BONE Inc | SIBN | 0.68% | 7.94K | $154.7K |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 2.49% | Paid (last 12 months) | $1.1219 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 22, 2026 | Last payment | $0.0290 (Jun 26, 2026) |
| Growth 1Y | +256.20% | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 22, 2026 | Jun 22, 2026 | Jun 26, 2026 | $0.0290 |
| Mar 23, 2026 | Mar 23, 2026 | Mar 27, 2026 | $0.0611 |
| Dec 22, 2025 | Dec 22, 2025 | Dec 26, 2025 | $0.6326 |
| Sep 22, 2025 | Sep 22, 2025 | Sep 26, 2025 | $0.3993 |
| Jun 23, 2025 | Jun 23, 2025 | Jun 27, 2025 | $0.0917 |
| Mar 24, 2025 | Mar 24, 2025 | Mar 28, 2025 | $0.0615 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 27, 2024 | $0.0482 |
| Sep 23, 2024 | Sep 23, 2024 | Sep 27, 2024 | $0.1136 |
| Mar 18, 2024 | Mar 19, 2024 | Mar 22, 2024 | $0.0672 |
| Dec 18, 2023 | Dec 19, 2023 | Dec 22, 2023 | $0.0371 |
| Sep 18, 2023 | Sep 19, 2023 | Sep 22, 2023 | $0.0284 |
| Jun 20, 2023 | Jun 21, 2023 | Jun 23, 2023 | $0.0356 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 26.96% / 28.83% | Sharpe 1Y / 3Y | 2.05 / 0.845 |
| Max drawdown 1Y / 3Y | -13.63% / -34.31% | Sortino 1Y | 3.15 |
| Beta vs S&P 500 (3Y) | 1.41 | Correlation vs S&P 500 (1Y) | 0.783 |
| Downside deviation 1Y | 17.53% | Risk-free rate used | 3.71% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 27, 2026. Formulas →
Liquidity
| Volume today | 3.55K | Average volume | 7.85K |
| AUM | $23.1M | Premium/Discount | -0.38% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $421.5K | +1.86% | $22.6M → $23.1M |
| 1 Week | -$5.2K | -0.02% | $22.8M → $23.1M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for QQQS
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.